CTAP
CTAP is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction.
Product Specifications
Purity
≥95%
Molecular Weight
1102.33
Notes
For research use only.
AA Sequence
{D-Phe}-CY-{D-Trp}-RT-{Pen}-T-NH2 (Disulfide bridge:Cys2-Pen7)
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog